LisaOstroskySproatMDMSW
Oncology • Scottsdale, AZClinical Director, Acute and Chronic Leukemia Program
Dr. Sproat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13400 E Shea Blvd
Scottsdale, AZ 85259Phone+1 480-301-8000
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2006 - 2009
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Vermont College of MedicineClass of 2000
Certifications & Licensure
AZ State Medical License 2009 - 2025
NM State Medical License 2015 - 2025
OH State Medical License 2005 - 2010
ME State Medical License Active through 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 5 citationsDoes early chimerism testing predict outcomes after allogeneic hematopoietic stem cell transplantationLuke Mountjoy, Jeanne Palmer, Katie L. Kunze, Nandita Khera, Lisa Z. Sproat
Leukemia & Lymphoma. 2021-01-02 - 23 citationsAllogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.Richard F. Ambinder, Juan Wu, Brent R. Logan, Christine M. Durand, Ryan K. Shields
Biology of Blood and Marrow Transplantation. 2019-11-01 - 9 citationsImpact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALLZaid Abdel Rahman, Michael G. Heckman, Kevin C. Miller, Hassan B. Alkhateeb, Mrinal S. Patnaik
Transplantation and Cellular Therapy. 2021-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
